表纸
市场调查报告书

动物用医药品的全球市场:机会及策略 (到2030年) - 各药物类型 (驱虫剂,疫苗,抗生素等)·各动物类别·各给药途径 (口服药等)·各最终用途

Veterinary Pharmaceuticals Global Market Opportunities And Strategies To 2030; By Type Of Pharmaceutical: Veterinary Parasiticides/Vaccines; Others - Veterinary Pharmaceuticals/Antibiotics; Animal Type; Route of Administration: Oral; Others; End-Use

出版商 The Business Research Company 商品编码 918124
出版日期 内容资讯 英文 486 Pages
商品交期: 2-3个工作天内
价格
Back to Top
动物用医药品的全球市场:机会及策略 (到2030年) - 各药物类型 (驱虫剂,疫苗,抗生素等)·各动物类别·各给药途径 (口服药等)·各最终用途 Veterinary Pharmaceuticals Global Market Opportunities And Strategies To 2030; By Type Of Pharmaceutical: Veterinary Parasiticides/Vaccines; Others - Veterinary Pharmaceuticals/Antibiotics; Animal Type; Route of Administration: Oral; Others; End-Use
出版日期: 2020年01月07日内容资讯: 英文 486 Pages
简介

本报告提供全球动物用医药品的市场相关分析,提供市场的主要特征·结构,及整体市场规模·成长率趋势预测 (过去5年·今后10年份),跟各领域·各地区·主要国家详细趋势,主要的宏觀经济指标·相关产业指标的对比,主要企业的简介,近几年主要的企业合并·收购 (M&A),相关市场结构·趋势等调查。

第1章 摘要整理:干洗/洗衣店服务

第2章 目录

第3章 图一览

第4章 表格一览

第5章 分析结构

第6章 简介

第7章 市场特征:动物用医药品

  • 市场定义
  • 市场区隔:各类型产品
    • 动物用疫苗
    • 动物用抗生素
    • 动物用驱虫剂
    • 其他
  • 市场区隔:各终端用户
    • 动物医院
    • 动物诊所
    • 药局·药妆店
  • 市场区隔:各给药途径 (RoA)
    • 口服药
    • 其他
  • 市场区隔:各动物类别
    • 家畜
    • 宠物
  • 市场区隔:各疫苗类别
    • 不活化疫苗
    • 弱毒化疫苗
    • 基因改造疫苗
    • 其他
  • 市场区隔:各抗生素类别
    • 四环霉素
    • 青霉素
    • 磺胺类药物
    • 大环内酯类
    • 氨基糖苷
    • 其他

第8章 动物用医药品市场:供应链分析

  • 供应链
    • 原料供应商
    • CRO (医药品临床研究委外机构)
    • 动物用医药品厂商
    • CMO (医药品受托制造厂商)
    • 批发商/经销商
    • 零售业者 (动物用药局等)·动物医院
    • 终端用户

第9章 动物用医药品市场:产品分析 - 产品案例

第10章 动物用医药品市场:客户资讯

  • 鸦片类药物短缺迫使兽医使用效果不佳的药物作为治疗选择
  • 美国兽医不愿讨论大麻在狗中的治疗用途
  • 在过去的几年中,美国的宠物拥有量增加了两倍
  • 猫狗药物仍主要在兽​​医诊所出售
  • 美国的宠物保险普及率很低
  • 宠物肥胖仍然是一个大问题
  • 宠物主人越了解有关人类与动物之间纽带关系的科学研究,他们就越有可能采取行动改善宠物健康。
  • 狗和猫的主人都担心宠物的医疗费用

第11章 动物用医药品市场趋势与策略

  • 推动创新的战略合作与伙伴关系
  • 咀嚼片的开发
  • 生产动物护理用通用药物
  • 纳米技术在兽医学中解决抗生素耐药性的应用
  • 治疗猫高血压用口服药物溶液
  • 次单元疫苗和VLP (类病毒颗粒) 疫苗的活用
  • 免疫疗法的使用

第12章 全球动物用医药品市场:法规环境

  • 兽药行业需要单独监管
  • 目前法规方案:美国,欧洲,印度,巴西,澳洲·纽西兰,非洲
  • 地区间法规的差异
  • 协调世界各国法规的配合措施
  • 动物用医药品取向法规:近几年的修改动向

第13章 兽医服务对动物用医药品市场的影响力

  • 各国分析 (美国,日本,中国,英国,德国)

第14章 动物用医药品:市场规模·成长率

  • 市场规模的实际成果值·预测值 (以金额为准)
    • 目前推动市场要素
      • 新兴国家市场成长
      • 宠物支出额的增加
      • 强化疾病预防的措施
    • 目前阻碍市场要素
      • 兽医不足
    • 未来性的推动市场要素
      • 经济发展
      • 宠物保险的普及
    • 未来性的阻碍市场要素

第15章 全球动物用医药品市场:市场区隔

  • 市场规模:医各类型药品 (以金额为准,实际成果值·预测值)
  • 市场规模:各动物类别 (以金额为准,实际成果值·预测值)
  • 市场规模:各给药途径 (以金额为准,实际成果值·预测值)
  • 市场规模:各最终用途 (以金额为准,实际成果值·预测值)

第16章 全球动物用医药品市场明细

  • 市场规模:各疫苗类别 (以金额为准,实际成果值·预测值)
  • 市场规模:各抗生素类别 (以金额为准,实际成果值·预测值)

第17章 全球动物用医药品市场:各地区·各国分析

  • 市场规模:各地区 (以金额为准,实际成果值·预测值)
  • 市场规模:各国 (以金额为准,实际成果值·预测值)

第18章 亚太地区的动物用医药品市场

  • 市场概要
    • 背景情况,政府的辅助策略·补助金制度,管理体制,税制,主要企业,近几年的投资趋势等
  • 市场规模 (以金额为准,实际成果值·预测值)
  • 市场规模:各类型药品 (实际成果值·预测值)
  • 市场规模:各动物类别 (实际成果值·预测值)
  • 市场规模:各最终用途 (实际成果值·预测值)
  • 市场规模:各抗生素类别 (实际成果值·预测值)
  • 各国分析
  • 中国市场
    • 市场概要
    • 市场规模 (以金额为准,总计9年份)
    • 按按市场规模:各类医药品/动物/最终用途/抗生素 (以金额为准,总计9年份)
  • 印度市场
  • 日本市场
  • 澳洲市场
  • 印尼市场
  • 韩国市场

第19章 西欧的动物用医药品市场

  • 英国市场
  • 德国市场
  • 法国市场

第20章 东欧的动物用医药品市场

  • 俄罗斯市场

第21章 北美的动物用医药品市场

  • 美国市场

第22章 南美的动物用医药品市场

  • 巴西市场

第23章 中东的动物用医药品市场

第24章 非洲的动物用医药品市场

第25章 市场竞争环境:全球动物用医药品市场

  • 企业简介
  • Zoetis Inc.
    • 企业概要
    • 主要产品与服务
    • 事业策略
    • 主要的财务指标
  • Boehringer Ingelheim International GmbH
  • Merck & Co., Inc.
  • Elanco Animal Health Inc.
  • Bayer AG

第26章 主要企业合并·收购 (M&A)的动向:动物用医药品市场的情况

第27章 市场背景情况:动物用医药品

  • 市场特征:动物用医药品市场
    • 市场定义
    • 主要的市场区隔
  • 动物用医药品市场:市场规模,各产业 (以金额为准,总计9年份)
  • 动物用医药品市场:市场规模,各地区 (以金额为准)
  • 动物用医药品市场:市场规模,实际成果值·预测值 (以金额为准,总计9年份)

第28章 全球干洗/洗衣店服务市场:机会及策略

  • 新的市场机会:各国
  • 新的市场机会:各领域
  • 市场成长策略
    • 市场趋势为基础策略
    • 各企业的策略

第29章 结论与建议

  • 结论
  • 建议
    • 产品·位置·价格·促销活动·人力资源等

第30章 附录

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录

Veterinary Pharmaceuticals Global Market Opportunities And Strategies To 2030 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global veterinary pharmaceuticals market.

Where is the largest and fastest growing market for the veterinary pharmaceuticals market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The global veterinary pharmaceutical market report to 2030 from the Business Research Company answers all these questions and many more.

The report covers the following chapters:

  • Executive Summary - The executive summary section of the report gives a brief overview and summary of the report
  • Report Structure - This section gives the structure of the report and the information covered in the various sections.
  • Introduction - The introduction section of the report gives brief introduction about segmentation by geography and segmentation by type.
  • Market Characteristics - The market characteristics section of the report defines and explains the veterinary pharmaceuticals market. This chapter includes different goods covered in the report and basic definitions.
  • Supply Chain - The supply chain section of the report defines and explains the key players in the veterinary pharmaceuticals industry supply chain.
  • Product Analysis - The product analysis section of the report describes the leading products in the market along with key features and differentiators for those products.
  • Customer Information - This chapters covers recent customers' trends/preferences in the global veterinary pharmaceuticals market.
  • Trends And Strategies - This chapter describes the major trends shaping the global veterinary pharmaceuticals market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
  • Regulatory Landscape - This section describes the current regulatory scenario, the regional disparities in regulations, global regulation harmonization initiatives, and recent updates on veterinary pharmaceutical regulations.
  • Impact Of Veterinary Services On The Veterinary Pharmaceuticals Market - This chapter describes the impact of veterinary services on the veterinary pharmaceuticals market, and comparison between the veterinary services, veterinary medical equipment and veterinary pharmaceuticals markets across major countries.
  • Global Market Size And Growth - This section contains the global historic (2015-2019) and forecast (2023, 2025 and 2030) market values, and drivers and restraints that support and restrain the growth of the market in the historic and forecast periods.
  • Market Segmentation - This section contains the market values (2015-2029, 2023, 2025 and 2030) and analysis for different segments and sub-segments in the market.
  • Regional And Country Analysis - This section contains the historic (2015-2019), forecast (2023, 2025 and 2030) market value and growth and market share comparison by region and countries.
  • Regional Market Size And Growth - This section contains the region's market size (2019), historic and forecast (2015-2019, 2023, 2025 and 2030) market values, and growth and market share comparison of major countries within the region. This report includes information on all the regions (Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa).
  • Competitive Landscape - This section covers details on the competitive landscape of the global veterinary pharmaceuticals market, estimated market shares and company profiles of the leading players.
  • Key Mergers And Acquisitions - This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Background - This section describes the animal medicine market of which the veterinary pharmaceuticals market is a segment. This chapter includes the animal medicine market 2015-23 values, and regional analyses for the animal medicine market.
  • Conclusions And Recommendations - This section includes conclusions and recommendations based on findings of the research. This section gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
  • Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report

Reasons to Purchase

  • Outperform competitors using accurate up to date demand-side dynamics information.
  • Identify growth segments for investment.
  • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
  • Create regional and country strategies on the basis of local data and analysis.
  • Stay abreast of the latest customer and market research findings
  • Benchmark performance against key competitors.
  • Develop strategies based on likely future developments.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Gain a global perspective on the development of the market.
1

Markets Covered

  • By Type Of Pharmaceutical: Veterinary Parasiticides; Veterinary Vaccines; Others - Veterinary Pharmaceuticals; Veterinary Antibiotics
  • By Animal Type: Livestock; Companion Animal
  • By Route of Administration: Oral; Others
  • By End-Use: Veterinary Hospitals; Pharmacies And Drug Stores; Veterinary Clinics
  • Companies Mentioned: Zoetis Inc.; Boehringer Ingelheim International GmbH; Merck & Co., Inc.; Elanco Animal Health Inc.; Bayer AG
  • Countries: China, India, Japan, Australia, South Korea, Indonesia, USA, Brazil, UK, Germany, France, Russia
  • Regions: Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
  • Time series: Five years historic and forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Veterinary Pharmaceuticals Market Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Introduction

    • 6.1.1. Segmentation By Geography
    • 6.1.2. By Type Of Pharmaceutical
    • 6.1.3. Segmentation By Animal Type
    • 6.1.4. Segmentation By Route of Administration
    • 6.1.5. Segmentation By End Use Channel

7. Veterinary Pharmaceuticals Market Characteristics

  • 7.1. Market Definition
  • 7.2. Market Segmentation By Type Of Product
    • 7.2.1. Veterinary Vaccines
    • 7.2.2. Veterinary Antibiotics
    • 7.2.3. Veterinary Parasiticides
    • 7.2.4. Others - Veterinary Pharmaceuticals
  • 7.3. Market Segmentation By End User
    • 7.3.1. Veterinary Hospitals
    • 7.3.2. Veterinary Clinics
    • 7.3.3. Pharmacies And Drug Stores
  • 7.4. Market Segmentation By Route Of Administration
    • 7.4.1. Oral
    • 7.4.2. Others
  • 7.5. Market Segmentation By Type Of Animal
    • 7.5.1. Livestock
    • 7.5.2. Companion Animals
  • 7.6. Market Segmentation By Vaccines
    • 7.6.1. Inactivated Vaccines
    • 7.6.2. Attenuated Vaccines
    • 7.6.3. Recombinant Vaccines
    • 7.6.4. Others
  • 7.7. Market Segmentation By Antibiotics
    • 7.7.1. Tetracyclines
    • 7.7.2. Penicillins
    • 7.7.3. Sulphonamides
    • 7.7.4. Macrolides
    • 7.7.5. Aminoglycosides
    • 7.7.6. Others

8. Veterinary Pharmaceuticals Market, Supply Chain Analysis

    • 8.1.1. Raw Material Suppliers
    • 8.1.2. Contract Research Organization (CRO)
    • 8.1.3. Veterinary Pharmaceutical Manufacturer
    • 8.1.4. Contract Manufacturing Organization (CMO)
    • 8.1.5. Wholesalers/Distributors
    • 8.1.6. Retailers (Pharmacies And Veterinary Shops) And Veterinary Clinics
    • 8.1.7. End-Users

9. Veterinary Pharmaceuticals Market, Product Analysis -Product Examples

10. Veterinary Pharmaceuticals Market Customer Information

    • 10.1.1. Opioids Shortages Compel Veterinarians To Use Less Effective Drugs As Therapeutic Choices
    • 10.1.2. U.S. Veterinarians Are Reluctant To Discuss The Therapeutic Use Of Marijuana In Dogs
    • 10.1.3. Pet Ownership In The USA Has Tripled Over The Past Few Years
    • 10.1.4. Cat And Dog Medications Are Still Sold Mainly In Veterinary Clinics
    • 10.1.5. Pet Insurance Penetration In The USA Is Very Low
    • 10.1.6. Pet Obesity Remains A Big Issue
    • 10.1.7. The More Pet Owners Learn About Scientific Research On The Benefits Of The Human-Animal Bond, The More Likely They Are To Take Actions To Improve Pet Health.
    • 10.1.8. Dog And Cat Owners Alike Are Concerned About The Cost Of Medical Treatments For Their Pets

11. Veterinary Pharmaceuticals Market Trends And Strategies

  • 11.1. Strategic Collaborations And Partnerships To Drive Innovations
  • 11.2. Development Of Chewable Tablets
  • 11.3. Production Of Generic Drugs For Animal Care
  • 11.4. Application Of Nanotechnology In Veterinary Medicines To Tackle Antibiotic Resistance
  • 11.5. Oral Drug Solutions For The Treatment Of Feline Hypertension
  • 11.6. Use of Subunit And Virus-Like Particle (VLP)-Based Vaccines
  • 11.7. Use Of Immunotherapy

12. Global Veterinary Pharmaceuticals Market Regulatory Landscape

  • 12.1. Need For Separate Regulation For The Veterinary Pharmaceuticals Industry
  • 12.2. Current Regulatory Scenario
    • 12.2.1. USA
    • 12.2.2. Europe
    • 12.2.3. India
    • 12.2.4. Brazil
    • 12.2.5. Australia and New Zealand
    • 12.2.6. Africa
  • 12.3. Regional Disparities In Regulations
    • 12.3.1. Lack Of Regulatory Guidance
    • 12.3.2. Variations In Veterinary Pharmaceuticals Development Processes
    • 12.3.3. Variations In Safety Considerations For Veterinary Pharmaceuticals
    • 12.3.4. Differences In Registration Procedures
  • 12.4. Global Regulation Harmonization Initiatives
  • 12.5. Recent Updates On Veterinary Pharmaceutical Regulations

13. Impact Of Veterinary Services On The Veterinary Pharmaceuticals Market

    • 13.1.1. USA
    • 13.1.2. Japan
    • 13.1.3. China
    • 13.1.4. UK
    • 13.1.5. Germany

14. Global Veterinary Pharmaceuticals Market Size And Growth

  • 14.1. Historic And Forecast Market Growth, Value ($ Million)
    • 14.1.1. Drivers Of The Market 2015-2019
    • 14.1.2. Emerging Markets Growth
    • 14.1.3. Increased Pet Spending
    • 14.1.4. Increased Disease Prevalence
    • 14.1.5. Restraints On The Market 2015-2019
    • 14.1.6. Shortages Of Veterinarians
    • 14.1.7. Drivers Of The Market 2019-2023
    • 14.1.8. Economic Growth
    • 14.1.9. Increasing Penetration Of Pet Insurance
    • 14.1.10. Restraints On The Market 2019-2023

15. Global Veterinary Pharmaceuticals Market Segmentation

  • 15.1. Global Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 15.2. Global Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 15.3. Global Veterinary Pharmaceuticals Market, Segmentation By Route of Administration, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 15.4. Global Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)

16. Global Veterinary Pharmaceuticals Market Sub-Segmentation

  • 16.1. Global Veterinary Vaccines Market, Segmentation By Type Of Vaccine, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 16.2. Global Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)

17. Veterinary Pharmaceuticals Market, Regional And Country Analysis

  • 17.1. Global Veterinary Pharmaceuticals Market, By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 17.2. Global Veterinary Pharmaceuticals Market, By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)

18. Asia-Pacific Veterinary Pharmaceuticals Market

  • 18.1. Asia-Pacific Veterinary Pharmaceuticals Market Overview
    • 18.1.1. Region Information
    • 18.1.2. Market Information
    • 18.1.3. Background Information
    • 18.1.4. Government Initiatives
    • 18.1.5. Regulatory Bodies
    • 18.1.6. Regulations
    • 18.1.7. Corporate Tax Structure
    • 18.1.8. Associations
    • 18.1.9. Tax Levied
    • 18.1.10. Investments
    • 18.1.11. Major Companies
  • 18.2. Asia-Pacific Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • 18.3. Asia-Pacific Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.4. Asia-Pacific Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.5. Asia-Pacific Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.6. Asia-Pacific Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.7. Asia-Pacific Veterinary Pharmaceuticals Market: Country Analysis
  • 18.8. China Veterinary Pharmaceuticals Market
  • 18.9. China Veterinary Pharmaceuticals Market Overview
    • 18.9.1. Country Information
    • 18.9.2. Market Information
    • 18.9.3. Background Information
    • 18.9.4. Regulatory Bodies
    • 18.9.5. Regulations
    • 18.9.6. Corporate Tax Structure
    • 18.9.7. Associations
    • 18.9.8. Tax Levied
    • 18.9.9. Investments
    • 18.9.10. Major Companies
  • 18.10. China Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • 18.11. China Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.12. China Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.13. China Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.14. China Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.15. India Veterinary Pharmaceuticals Market
  • 18.16. India Veterinary Pharmaceuticals Market Overview
    • 18.16.1. Country Information
    • 18.16.2. Market Information
    • 18.16.3. Background Information
    • 18.16.4. Government Initiatives
    • 18.16.5. Regulatory Bodies
    • 18.16.6. Regulations
    • 18.16.7. Corporate Tax Structure
    • 18.16.8. Associations
    • 18.16.9. Tax Levied
    • 18.16.10. Investments
    • 18.16.11. Major Companies
  • 18.17. India Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • 18.18. India Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.19. India Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.20. India Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.21. India Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.22. Japan Veterinary Pharmaceuticals Market
  • 18.23. Japan Veterinary Pharmaceuticals Market Overview
    • 18.23.1. Country Information
    • 18.23.2. Market Information
    • 18.23.3. Background Information
    • 18.23.4. Government Initiatives
    • 18.23.5. Regulatory Bodies
    • 18.23.6. Regulations
    • 18.23.7. Corporate Tax Structure
    • 18.23.8. Associations
    • 18.23.9. Tax Levied
    • 18.23.10. Investments
    • 18.23.11. Major Companies
  • 18.24. Japan Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • 18.25. Japan Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.26. Japan Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.27. Japan Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.28. Japan Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.29. Australia Veterinary Pharmaceuticals Market
  • 18.30. Australia Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • 18.31. Australia Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.32. Australia Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.33. Australia Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.34. Australia Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.35. Indonesia Veterinary Pharmaceuticals Market
  • 18.36. Indonesia Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • 18.37. Indonesia Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.38. Indonesia Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.39. Indonesia Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.40. Indonesia Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.41. South Korea Veterinary Pharmaceuticals Market
  • 18.42. South Korea Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • 18.43. South Korea Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.44. South Korea Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.45. South Korea Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 18.46. South Korea Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)

19. Western Europe Veterinary Pharmaceuticals Market

  • 19.1. Western Europe Veterinary Pharmaceuticals Market Overview
    • 19.1.1. Region Information
    • 19.1.2. Market Information
    • 19.1.3. Background Information
    • 19.1.4. Government Initiatives
    • 19.1.5. Regulatory Bodies
    • 19.1.6. Regulations
    • 19.1.7. Corporate Tax Structure
    • 19.1.8. Associations
    • 19.1.9. Investments
    • 19.1.10. Major Companies
  • 19.2. Western Europe Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • 19.3. Western Europe Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 19.4. Western Europe Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 19.5. Western Europe Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 19.6. Western Europe Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 19.7. Western Europe Veterinary Pharmaceuticals Market: Country Analysis
  • 19.8. UK Veterinary Pharmaceuticals Market
  • 19.9. UK Veterinary Pharmaceuticals Market Overview
    • 19.9.1. Country Information
    • 19.9.2. Market Information
    • 19.9.3. Background Information
    • 19.9.4. Government Initiatives
    • 19.9.5. Regulatory Bodies
    • 19.9.6. Regulations
    • 19.9.7. Corporate Tax Structure
    • 19.9.8. Associations
    • 19.9.9. Investments
    • 19.9.10. Major Companies
  • 19.10. UK Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • 19.11. UK Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 19.12. UK Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 19.13. UK Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 19.14. UK Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 19.15. Germany Veterinary Pharmaceuticals Market
  • 19.16. Germany Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • 19.17. Germany Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 19.18. Germany Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 19.19. Germany Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 19.20. Germany Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 19.21. France Veterinary Pharmaceuticals Market
  • 19.22. France Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • 19.23. France Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 19.24. France Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 19.25. France Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 19.26. France Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)

20. Eastern Europe Veterinary Pharmaceuticals Market

  • 20.1. Eastern Europe Veterinary Pharmaceuticals Market Overview
    • 20.1.1. Region Information
    • 20.1.2. Market Information
    • 20.1.3. Background Information
    • 20.1.4. Regulatory Bodies
    • 20.1.5. Regulations
    • 20.1.6. Corporate Tax Structure
    • 20.1.7. Associations
    • 20.1.8. Tax Levied
    • 20.1.9. Investment
    • 20.1.10. Major Companies
  • 20.2. Eastern Europe Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • 20.3. Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 20.4. Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 20.5. Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 20.6. Eastern Europe Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 20.7. Eastern Europe Veterinary Pharmaceuticals Market: Country Analysis
  • 20.8. Russia Veterinary Pharmaceuticals Market
  • 20.9. Russia Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • 20.10. Russia Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 20.11. Russia Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 20.12. Russia Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 20.13. Russia Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)

21. North America Veterinary Pharmaceuticals Market

  • 21.1. North America Veterinary Pharmaceuticals Market Overview
    • 21.1.1. Region Information
    • 21.1.2. Market Information
    • 21.1.3. Background Information
    • 21.1.4. Government Initiatives
    • 21.1.5. Regulatory Bodies
    • 21.1.6. Regulations
    • 21.1.7. Corporate Tax Structure
    • 21.1.8. Associations
    • 21.1.9. Tax Levied
    • 21.1.10. Investments
    • 21.1.11. Major Companies
  • 21.2. North America Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • 21.3. North America Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 21.4. North America Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 21.5. North America Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 21.6. North America Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 21.7. North America Veterinary Pharmaceuticals Market: Country Analysis
  • 21.8. USA Veterinary Pharmaceuticals Market
  • 21.9. USA Veterinary Pharmaceuticals Market Overview
    • 21.9.1. Region Information
    • 21.9.2. Market Information
    • 21.9.3. Background Information
    • 21.9.4. Government Initiatives
    • 21.9.5. Regulatory Bodies
    • 21.9.6. Regulations
    • 21.9.7. Corporate Tax Structure
    • 21.9.8. Associations
    • 21.9.9. Tax Levied
    • 21.9.10. Investments
    • 21.9.11. Major Companies
  • 21.10. USA Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • 21.11. USA Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 21.12. USA Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 21.13. USA Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 21.14. USA Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)

22. South America Veterinary Pharmaceuticals Market

  • 22.1. South America Veterinary Pharmaceuticals Market Overview
    • 22.1.1. Region Information
    • 22.1.2. Market Information
    • 22.1.3. Background Information
    • 22.1.4. Regulatory Bodies
    • 22.1.5. Regulations
    • 22.1.6. Corporate Tax Structure
    • 22.1.7. Associations
    • 22.1.8. Tax Levied
    • 22.1.9. Investments
    • 22.1.10. Major Companies
  • 22.2. South America Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • 22.3. South America Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 22.4. South America Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 22.5. South America Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 22.6. South America Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 22.7. South America Veterinary Pharmaceuticals Market: Country Analysis
  • 22.8. Brazil Veterinary Pharmaceuticals Market
  • 22.9. Brazil Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • 22.10. Brazil Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 22.11. Brazil Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 22.12. Brazil Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 22.13. Brazil Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)

23. Middle East Veterinary Pharmaceuticals Market

  • 23.1. Middle East Veterinary Pharmaceuticals Market Overview
    • 23.1.1. Region Overview
    • 23.1.2. Market Information
    • 23.1.3. Background Information
    • 23.1.4. Regulatory Bodies
    • 23.1.5. Regulations
    • 23.1.6. Corporate Tax Structure
    • 23.1.7. Associations
    • 23.1.8. Major Companies
  • 23.2. Middle East Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • 23.3. Middle East Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 23.4. Middle East Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 23.5. Middle East Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 23.6. Middle East Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)

24. Africa Veterinary Pharmaceuticals Market

  • 24.1. Africa Veterinary Pharmaceuticals Market Overview
    • 24.1.1. Region Information
    • 24.1.2. Market Information
    • 24.1.3. Background Information
    • 24.1.4. Regulatory Bodies
    • 24.1.5. Regulations
    • 24.1.6. Corporate Tax Structure
    • 24.1.7. Associations
    • 24.1.8. Investments
    • 24.1.9. Major Companies
  • 24.2. Africa Veterinary Pharmaceuticals Market, Historic And Forecast, 2015 - 2019, 2023F, 2025F, 2030F, $ Million
  • 24.3. Africa Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceutical, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 24.4. Africa Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 24.5. Africa Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)
  • 24.6. Africa Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2019, 2023F, 2025F, 2030F, Value ($ Million)

25. Global Veterinary Pharmaceuticals Market Competitive Landscape

  • 25.1. Company Profiles
  • 25.2. Zoetis Inc.
    • 25.2.1. Company Overview
    • 25.2.2. Products And Services
    • 25.2.3. Business Strategy
    • 25.2.4. Financial Overview
  • 25.3. Boehringer Ingelheim International GmbH
    • 25.3.1. Company Overview
    • 25.3.2. Products And Services
    • 25.3.3. Business Strategy
    • 25.3.4. Financial Overview
  • 25.4. Merck & Co., Inc.
    • 25.4.1. Company Overview
    • 25.4.2. Products And Services
    • 25.4.3. Business Strategy
    • 25.4.4. Financial Overview
  • 25.5. Elanco Animal Health Inc.
    • 25.5.1. Company Overview
    • 25.5.2. Products And Services
    • 25.5.3. Business Strategy
    • 25.5.4. Financial Overview
  • 25.6. Bayer AG
    • 25.6.1. Company Overview
    • 25.6.2. Products And Services
    • 25.6.3. Business Strategy
    • 25.6.4. Financial overview

26. Key Mergers And Acquisitions In The Veterinary Pharmaceuticals Market

  • 26.1. Elanco Animal Health Acquired Bayer's AG
  • 26.2. Merck Animal Health Acquired Antelliq Corporation
  • 26.3. Henry Schein Animal Health Merges With Vets First Choice
  • 26.4. Mars Petcare Acquired AniCura
  • 26.5. PHARMAQ Collaborated With Vinh Hoan
  • 26.6. Animal Health Division Of Merck & Co. Collaborated With Vinovo
  • 26.7. Wageningen Bioveterinary Research Collaborated With Ceva
  • 26.8. Animalcare Group Acquired Ecuphar
  • 26.9. Merck Animal Health Acquired Vallee S.A.
  • 26.10. Elanco Animal Health Acquired Boehringer Ingelheim Vetmedica's Vaccine Portfolio
  • 26.11. Ceva Acquired Portfolio Of Merial Swine And Cattle Vaccines
  • 26.12. Dechra Holdings US (A U.S Subsidiary of Dechra Pharmaceuticals PLC Acquired Putney Inc.
  • 26.13. Zydus Cadila Acquired Zoetis
  • 26.14. Eli Lilly And Company Acquired Novartis Animal Health

27. Market Background: Animal Medicine

  • 27.1. Animal Medicine Market Characteristics
    • 27.1.1. Market Definition
    • 27.1.2. Segmentation Type Of Medicine
  • 27.2. Global Animal Medicine Market, Segmentation By Industry, 2015 - 2023, Value ($ Million)
  • 27.3. Global Animal Medicine Market, 2019, By Region, Value ($ Million)
  • 27.4. Global Animal Medicine Market, 2015 - 2023, Historic And Forecast, By Region

28. Global Veterinary Pharmaceuticals Market Opportunities And Strategies

  • 28.1. Global Veterinary Pharmaceuticals Market In 2023 - Countries Offering Most New Opportunities
  • 28.2. Global Veterinary Pharmaceuticals Market In 2023 - Segments Offering Most New Opportunities
  • 28.3. Global Veterinary Pharmaceuticals Market In 2023 - Growth Strategies
    • 28.3.1. Market Trend Based Strategies
    • 28.3.2. Competitor Strategies

29. Veterinary Pharmaceuticals Market, Conclusions And Recommendations

  • 29.1. Conclusions
  • 29.2. Recommendations
    • 29.2.1. Product
    • 29.2.2. Place
    • 29.2.3. Price
    • 29.2.4. Promotion
    • 29.2.5. People

30. Appendix

  • 30.1. Market Data Sources
  • 30.2. Research Methodology
  • 30.3. Currencies
  • 30.4. Research Inquiries
  • 30.5. The Business Research Company
  • 30.6. Copyright and Disclaimer
Back to Top